Time To Take A Stand To Protect Scientists Performing Animal Research Biological Psychiatry, in its upcoming April 15th issue, is publishing a critically important commentary written by its Editors, members of its Editorial Committee, and its Editorial Board.
Source: www.medicalnewstoday.comSorafenib Monotherapy In Patients With Metastatic Renal Cell Cancer: A Phase II Intra-Patient Dose Escalation Study UroToday.com - Sorafenib 400 mg b.i.d. has shown anti-tumor activity and favorable tolerability in patients with metastatic renal cell carcinoma (RCC), allowing investigation of more intensive drug administration regimens. This titration study allowed individual patients to escalate to higher doses of sorafenib.
Source: www.medicalnewstoday.comNovel 'Gene Toggles' Discovered By UD Researchers University of Delaware researchers, in collaboration with U.S. and international colleagues, have found a new type of molecule--a kind of "micro-switch"--that can turn off genes in rice, which is the primary source of food for more than half the world's population.
Source: www.medicalnewstoday.comUK Food Standards Agency Cites Southampton Study In New Recommendation On Food Additives The Food Standards Agency announced its decision to recommend to Ministers the phasing out of six colours in food and drink in the EU.
Source: www.medicalnewstoday.comManagement Of Superficial Bladder Tumors UroToday.
Source: www.medicalnewstoday.comNew Class Of Anti-Cancer Drugs That Target PI 3-kinase In Clinical Trials The Institute of Cancer Research announces that a drug candidate, first identified during a research collaboration with UK biotechnology company Piramed Limited, is in clinical development. The trials are currently underway in the UK at The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust and in the U.S.
Source: www.medicalnewstoday.com
# posted by Network @ 5:00 AM
